MedTrace Logo

Nd:Yttrium Aluminum Garnet Laser Treatment for Lichen Sclerosus

NCT03525522 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-05-15

No results posted yet for this study

Summary

This study evaluates the efficacy of Nd:Yttrium Aluminum Garnet Laser (Nd:YAG) Treatment of Lichen sclerosus in comparison with topical corticosteroid treatment. Half of participants will receive laser treatment and the other half corticosteroid treatment and the results will be followed for 6 months.

Conditions

  • Lichen Sclerosus
  • Lichen Sclerosus Et Atrophicus

Interventions

DEVICE

Nd:YAG Laser

Three sessions of Nd:YAG treatment every two weeks.

DRUG

Topical corticosteroid Diprosone

3 months of topical corticosteroids Diprosone

Sponsors & Collaborators

  • Juna d.o.o.

    collaborator INDUSTRY

  • Dr Adolf Lukanovič

    lead OTHER

Principal Investigators

  • Adolf Lukanović, PhD · UKC Ljubljana

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-28
Primary Completion
2018-05-30
Completion
2018-05-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03525522 on ClinicalTrials.gov